Alpha-synuclein is a cellular ferrireductase

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Davies, Paul ^a   Moualla, Dima ^a   Brown, David R ^a  

^a University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; COPPER; FERRIC ION; FERROUS ION; IRON REDUCTASE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG; FERRIC CITRATE IRON REDUCTASE; FLAVINE MONONUCLEOTIDE REDUCTASE; IRON; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; CELL LYSATE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IRON TRANSPORT; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; CELL LINE; DIFFUSE LEWY BODY DISEASE; ENZYMOLOGY; KINETICS; METABOLISM; NERVE CELL; PARKINSON DISEASE; PHYSIOLOGY;

ALPHA-SYNUCLEIN; CELL LINE; COPPER; FMN REDUCTASE; HUMANS; IRON; KINETICS; LEWY BODY DISEASE; NAD; NEURONS; PARKINSON DISEASE;

EID: 79251572323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015814     Document Type: Article

References (31)

1. Burke RE (2004) Recent advances in research on Parkinson disease: synuclein and parkin. Neurologist 10: 75-81.
2. Beyer K, Domingo-Sabat M, Ariza A (2009) Molecular pathology of Lewy body diseases. Int J Mol Sci 10: 724-745.
3. Beyer K (2007) Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane. Cell Biochem Biophys 47: 285-299.
4. Rasia RM, Bertoncini CW, Marsh D, Hoyer W, Cherny D, et al. (2005) Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease. Proc Natl Acad Sci U S A 102: 4294-4299.
5. Bharathi, Rao KS (2007) Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease. Biochem Biophys Res Commun 359: 115-120.
6. Binolfi A, Rasia RM, Bertoncini CW, Ceolin M, Zweckstetter M, et al. (2006) Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement. J Am Chem Soc 128: 9893-9901.
7. Paik SR, Shin HJ, Lee JH, Chang CS, Kim J (1999) Copper(II)-induced selfoligomerization of alpha-synuclein. Biochemical Journal 340: 821-828.
8. Lee EN, Lee SY, Lee D, Kim J, Paik SR (2003) Lipid interaction of alphasynuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2. Journal of Neurochemistry 84: 1128-1142.
9. Binolfi A, Lamberto GR, Duran R, Quintanar L, Bertoncini CW, et al. (2008) Site-specific interactions of Cu(II) with alpha and beta-synuclein: Bridging the molecular gap between metal binding and aggregation. Journal of the American Chemical Society 130: 11801-11812.
10. Yu S, Ueda K, Chan P (2005) Alpha-synuclein and dopamine metabolism. Mol Neurobiol 31: 243-254.
11. Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, et al. (2002) A role for alphasynuclein in the regulation of dopamine biosynthesis. J Neurosci 22: 3090-3099.
12. Yu S, Zuo X, Li Y, Zhang C, Zhou M, et al. (2004) Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Neurosci Lett 367: 34-39.
13. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, et al. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239-252.
14. Kienzl E, Jellinger K, Stachelberger H, Linert W (1999) Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease? Life Sciences 65: 1973-1976.
15. Charkoudian LK, Franz KJ (2006) Fe(III)-coordination properties of neuromelanin components: 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid. Inorganic Chemistry 45: 3657-3664.
16. Davies P, Marken F, Salter S, Brown DR (2009) Thermodynamic and voltammetric characterization of the metal binding to the prion protein: insights into pH dependence and redox chemistry. Biochemistry 48: 2610-2619.
17. Riemer J, Hoepken HH, Czerwinska H, Robinson SR, Dringen R (2004) Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal Biochem 331: 370-375.
18. Galvin JE, Lee VM, Trojanowski JQ (2001) Synucleinopathies: clinical and pathological implications. Arch Neurol 58: 186-190.
19. Goedert M, Spillantini MG (1998) Lewy body diseases and multiple system atrophy as alpha-synucleinopathies. Mol Psychiatry 3: 462-465.
20. Uversky VN (2008) Alpha-synuclein misfolding and neurodegenerative diseases. Curr Protein Pept Sci 9: 507-540.
21. Lotharius J, Brundin P (2002) Impaired dopamine storage resulting from alphasynuclein mutations may contribute to the pathogenesis of Parkinson's disease. Hum Mol Genet 11: 2395-2407.
22. Binolfi A, Lamberto GR, Duran R, Quintanar L, Bertoncini CW, et al. (2008) Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation. J Am Chem Soc 130: 11801-11812.
23. Brown DR (2009) Metal binding to alpha-synuclein peptides and its contribution to toxicity. Biochem Biophys Res Commun 380: 377-381.
24. Drew SC, Leong SL, Pham CL, Tew DJ, Masters CL, et al. (2008) Cu2+ binding modes of recombinant alpha-synuclein-insights from EPR spectroscopy. J Am Chem Soc 130: 7766-7773.
25. Lee JC, Gray HB, Winkler JR (2008) Copper(II) binding to alpha-synuclein, the Parkinson's protein. J Am Chem Soc 130: 6898-6899.
26. Sung YH, Rospigliosi C, Eliezer D (2006) NMR mapping of copper binding sites in alpha-synuclein. Biochim Biophys Acta 1764: 5-12.
27. Hong L, Simon JD (2009) Binding of Cu(II) to human alpha-synucleins: comparison of wild type and the point mutations associated with the familial Parkinson's disease. J Phys Chem B 113: 9551-9561.
28. Simovich MJ, Conrad ME, Umbreit JN, Moore EG, Hainsworth LN, et al. (2002) Cellular location of proteins related to iron absorption and transport. Am J Hematol 69: 164-170.
29. Masserano JM, Weiner N (1983) Tyrosine hydroxylase regulation in the central nervous system. Mol Cell Biochem 53-54: 129-152.
30. Wolozin B, Golts N (2002) Iron and Parkinson's disease. Neuroscientist 8: 22-32.
31. Wright JA, Wang X, Brown DR (2009) Unique copper-induced oligomers mediate alpha-synuclein toxicity. Faseb J 23: 2384-2393.